CombinedX (CX) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
11 Feb, 2026Executive summary
Achieved record Q4 2025 revenue of 273.7 MSEK, up 6.1% year-over-year, with improved adjusted EBITA margin despite high restructuring costs.
Full-year 2025 revenue reached 947.7 MSEK, a 1.9% increase, with adjusted EBITA margin rising to 9.5% from 8.7% the previous year.
Pro forma 2025 revenue exceeded 1 billion SEK, driven by strategic acquisitions of Align and ERPkonsult.
Strategic shift towards building market-leading specialist brands and increased collaboration among subsidiaries.
Less focus on group-wide synergies, with openness to alternative growth paths, including potential spin-offs.
Financial highlights
Q4 2025 adjusted EBITA: 27.7 MSEK (margin 10.1%), up from 25.5 MSEK (margin 9.9%) in Q4 2024.
Full-year 2025 adjusted EBITA: 90.1 MSEK (margin 9.5%), up from 81.2 MSEK (margin 8.7%) in 2024.
Pro forma 2025 adjusted EBITA: 103.8 MSEK (margin 10.3%).
Net income for Q4 was 10.6 MSEK, down from 19.5 MSEK; full-year net income was 37.7 MSEK, down from 51.0 MSEK.
Proposed dividend of 1.00 SEK per share, down from 1.40 SEK.
Outlook and guidance
Strategic focus on add-on acquisitions, building specialist brands, and increased collaboration among subsidiaries.
Targeting organic growth above the IT consulting market and maintaining net debt below 2x EBITDA.
Signs of market improvement entering 2026, with focus on increasing billing rates and achieving a 12% adjusted EBITA margin.
Openness to alternative growth paths, including potential spin-offs of specialist companies.
No specific financial forecasts provided, but management expresses confidence in future prospects.
Latest events from CombinedX
- Strong revenue growth offset by sharply lower margins amid integration and market challenges.CX
Q2 202428 Jan 2026 - Q3 2025 saw higher margins and revenue, driven by acquisitions despite negative organic growth.CX
Q3 202524 Oct 2025 - Revenue declined and margins improved, with acquisitions supporting strategic growth.CX
Q2 202517 Jul 2025 - Sales up 27.5% but margins and organic growth fell; restructuring targets improved 2025 results.CX
Q3 202413 Jun 2025 - Q1 2025 saw 6.5% revenue growth and resilient margins despite market challenges.CX
Q1 20256 Jun 2025 - Revenue surged but organic growth and margins fell; acquisitions set up 2025 recovery.CX
Q4 20245 Jun 2025